Literature DB >> 22943850

The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background.

Abrar Hussain1, Joy Armistead, Lara Gushulak, Christa Kruck, Steven Pind, Barbara Triggs-Raine, Marvin R Natowicz.   

Abstract

Mutations of the glycogen branching enzyme gene, GBE1, result in glycogen storage disease (GSD) type IV, an autosomal recessive disorder having multiple clinical forms. One mutant allele of this gene, GBE1 c.1076A>C, has been reported in Ashkenazi Jewish cases of an adult-onset form of GSD type IV, adult polyglucosan body disease (APBD), but no epidemiological analyses of this mutation have been performed. We report here the first epidemiological study of this mutation in persons of Ashkenazi Jewish background and find that this mutation has a gene frequency of 1 in 34.5 (95% CI: 0.0145-0.0512), similar to the frequency of the common mutation causing Tay-Sachs disease among Ashkenazi Jews. This finding reveals APBD to be another monogenic disorder that occurs with increased frequency in persons of Ashkenazi Jewish ancestry.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22943850     DOI: 10.1016/j.bbrc.2012.08.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy.

Authors:  Rafael Alvarez; Jesús Casas; David J López; Maitane Ibarguren; Ariadna Suari-Rivera; Silvia Terés; Francisca Guardiola-Serrano; Alexander Lossos; Xavier Busquets; Or Kakhlon; Pablo V Escribá
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

Review 2.  Update on polyglucosan storage diseases.

Authors:  Giovanna Cenacchi; V Papa; R Costa; V Pegoraro; R Marozzo; M Fanin; C Angelini
Journal:  Virchows Arch       Date:  2019-07-30       Impact factor: 4.064

3.  Frequent misdiagnosis of adult polyglucosan body disease.

Authors:  Mark A Hellmann; Or Kakhlon; Ezekiel H Landau; Menachem Sadeh; Nir Giladi; Ilana Schlesinger; Daphne Kidron; Oded Abramsky; Avinoam Reches; Zohar Argov; Jose M Rabey; Joab Chapman; Hanna Rosenmann; Aya Gal; J Moshe Gomori; Vardiella Meiner; Alexander Lossos
Journal:  J Neurol       Date:  2015-07-21       Impact factor: 4.849

4.  Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration.

Authors:  Esther N Bit-Ivan; Kyung-Hwa Lee; Darren Gitelman; Sandra Weintraub; Marsel Mesulam; Rosa Rademakers; Adrian M Isaacs; Kimmo J Hatanpaa; Charles L White; Qinwen Mao; Orhan Akman; Salvatore DiMauro; Eileen H Bigio
Journal:  Neuropathol Appl Neurobiol       Date:  2014-10       Impact factor: 8.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.